NASDAQ: VIGL
Vigil Neuroscience Inc Stock Ownership - Who owns Vigil Neuroscience?

Insider buying vs selling

Have Vigil Neuroscience Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Haeberlein Samantha L. BuddDirector2024-12-1912,000$1.71
$20.52kBuy
Ivana MagovcevicliebischPresident and CEO2024-12-195,000$1.68
$8.40kBuy
Ivana MagovcevicliebischPresident and CEO2024-12-185,000$1.67
$8.35kBuy
Ivana MagovcevicliebischPresident and CEO2024-12-055,000$2.34
$11.70kBuy

1 of 1

VIGL insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when VIGL insiders and whales buy or sell their stock.

VIGL Shareholders

What type of owners hold Vigil Neuroscience Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Bruce Booth12.52%5,841,874$45.92MInsider
Atlas Venture Fund XII LP12.51%5,836,874$45.88MInsider
Atlas Venture Life Science Advisors LLC12.51%5,836,874$45.88MInstitution
Stefan Vitorovic10.78%5,032,465$39.56MInsider
Vida Ventures GP III LLC10.75%5,015,929$39.43MInsider
Northpond Ventures GP LLC9.03%4,214,498$33.13MInsider
Bvf Inc8.60%4,013,633$31.55MInstitution
Amgen Inc6.87%3,206,281$25.20MInsider
Siren LLC4.21%1,967,064$15.46MInstitution
683 Capital Management LLC3.73%1,740,000$13.68MInstitution

1 of 3

VIGL vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
VIGL44.05%55.95%Net Buying
FULC60.81%39.19%Net BuyingNet Selling
RIGL35.94%64.06%Net Selling
RZLT29.88%70.12%Net BuyingNet Buying
HUMA39.21%22.32%Net SellingNet Buying

Vigil Neuroscience Stock Ownership FAQ

Who owns Vigil Neuroscience?

Vigil Neuroscience (NASDAQ: VIGL) is owned by 53.63% institutional shareholders, 68.11% Vigil Neuroscience insiders, and 0.00% retail investors. Bruce Booth is the largest individual Vigil Neuroscience shareholder, owning 5.84M shares representing 12.52% of the company. Bruce Booth's Vigil Neuroscience shares are currently valued at $46.03M.

If you're new to stock investing, here's how to buy Vigil Neuroscience stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.